Director, Above Brand Analytics, Neuroscience
AbbVie
Summary
The Director of Above Brand Analytics, Neuroscience within APEX plays an instrumental role in maximizing opportunity for AbbVie's in-market and near-term pipeline products for the Neuroscience portfolio (Migraine, Psychology and Parkinson's franchises) & entire U.S. Area. The Director provides direct and in-direct leadership for all brand/indication combinations and is responsible for addressing the business needs across the Migraine, Psychology and Parkinson's franchises (marketing and sales).
Job description
Major Responsibilities
- Ensure the coordinated and consistent delivery of Neuroscience data structure, analytic insights and key performance metrics that facilitate franchise leaders to lead their business.
- Ensure consistent methods are deployed in areas that include data management, patient projection and patient flow modeling.
- Build advanced capabilities and adoption within direct and in-direct team members.
- Develop people in their Neuroscience-specific knowledge while also expanding their data analytic tool kit.
Strategy, Insights and Analytics
- Shape Neuroscience franchise and portfolio strategy by translating complex data and analytics into actionable recommendations that inform commercial priorities, investment decisions and execution.
- Provide objective performance narratives that integrate market dynamics, competitive evolution, patient/HCP behavior, access and promotional performance to identify opportunities and risks.
- Lead analytics supporting Neuroscience pipeline and commercialization priorities, including opportunity assessment, market and patient landscape evaluation, forecasting inputs, launch planning and early performance measurement.
- Connect pipeline insights with in-market learnings to inform commercialization strategy and enable successful transition from pipeline to launch.
- Partner with franchise leadership, Finance/Forecasting and other cross-functional stakeholders to provide analytical input into annual planning, long-range planning, forecasting assumptions, SG&A investment, targeting and business optimization decisions.
- Continue to advance analytics capabilities across Neuroscience, developing and gaining stakeholder alignment on a strategic roadmap spanning national and subnational analytics, pipeline analytics, reporting, advanced analytics and scalable decision-support capabilities.
- Anticipate recurring business questions and develop scalable reporting, diagnostic and self-service capabilities that shift the organization from reactive analysis toward proactive performance management.
- Advance Neuroscience reporting and tracking through automation, standardization and streamlined data and analytics workflows, reducing manual effort and improving speed and consistency of insights.
- Anticipate opportunities to improve decision-making through new data sources, analytical methodologies and technology capabilities, partnering with internal teams and external suppliers to develop and scale effective solutions.
Omnichannel, AI & Analytics Transformation
- Lead the Neuroscience AI Builder agenda, partnering with APEX Enterprise and BTS to identify, develop, operationalize and drive adoption of AI-enabled analytics solutions that address priority business needs and improve speed, scalability and quality of decision-making.
- Lead the Neuroscience omnichannel analytics and optimization agenda, integrating HCP, patient, consumer and digital engagement data to identify opportunities to improve customer experience, promotional effectiveness and business performance.
- Establish measurement frameworks and analytical approaches to evaluate channel and tactic performance, identify cross-channel interactions, and translate insights into actionable recommendations for marketing and franchise teams.
- Identify and prioritize opportunities to apply AI, advanced analytics and emerging technologies to recurring business questions, reducing manual effort and accelerating speed to insight.
- Establish appropriate analytical standards and governance for AI and advanced analytics solutions, including data quality, methodology, validation, documentation and adoption.
- Stay current on emerging omnichannel, AI and advanced analytics capabilities and determine where they can practically improve Neuroscience commercial decision-making.
Collaboration and Influence
- Build highly collaborative relationships with APEX Insights and Analytics, APEX Market Access, APEC Data Capabilities COE, Finance/Forecasting, APEX Patient Services, Sales Operations, Consumer marketing team, AbbVie PCS and Marketing/Sales leadership.
- Demonstrate indirect influence in driving franchise success while developing capabilities within APEX.
- Excel in leading through indirect influence with marketing teams, finance teams, innovation team, patient services and external consultants.
- Proactively educate the organization on critical concepts (both within team and outside of team).
- Be an advisor to the President, US Neuroscience, and VPs of each franchise (Migraine, Botox, Psych, and Parkinson's).
Team Leadership
- Lead the above brand analytics team in a manner that ensures the team advances the business, guiding the brand strategy and plan with leading analytic techniques and capabilities across consumer/patient, physician, brand, payor, and channel.
- Build, coach, and maintain a high-performing and diverse team of analytical, quantitative, and business-minded individuals that collectively distill business insights from commercial data sources and advanced analytic capabilities.
- Coach and teach others on functional, technical, and marketing best practices, financial acumen and how to translate complicated information into compelling stories and learning.
- Lead the development of state-of-the-art models that meet key business criteria (e.g., cost, risk, business impact) and key technical criteria (e.g., reliability, validity, and predictability).
- Identify and articulate fact-based spending and pricing principles through detailed analysis of marketplace and consumer dynamics.
- Guide franchise investment decisions from marketing mix/business optimization and other analysis.
- Coach Brand Analytic team members, including franchise financial planning process responsibilities: Pressure test and provide input to forecast assumptions based on knowledge of market, competitive dynamics, and upcoming events.
- Pressure test and provide input into financial planning process, both short term and long-range plans.
Requirements
- Bachelor's Degree in Computer Science, Engineering, Statistics, Economics, Decision Sciences, Operations Research, or Applied Mathematics
- 5+ years managing teams
- 10+ years of experience in quantitative analysis of sales and marketing information
- 10+ years of experience in marketing analytics
- 10+ years of experience in promotional data / measurement
- Working knowledge of multivariate statistics, analytical software, and pharmaceutical data sources (IQVIA, SHA, MMIT, SSR, CMS, Truven, etc.)
- Intimate knowledge of marketing, sales, logistics and financial planning processes
- Advanced quantitative expertise and systems understanding
- Strong visualization and storytelling skills
- Demonstrated project management skills
- Strong influence and leadership skills
- Adept in working with and analyzing syndicated pharma data (IQVIA, Symphony, etc.)
- Experience developing and deploying analytics solutions that address business needs
- Adept in navigating a matrix environment at a large company
Benefits
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.